Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chime Biologics

Request full access

Providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing

Wuhan, ChinaFounded 2013Biotech & Life Sciences

About Chime Biologics

Chime Biologics is a top-tier Contract Development and Manufacturing Organization (CDMO), specializing in biologics. In simpler terms, it helps other companies develop and manufacture biological drugs, which are medicines made from living organisms or their components. Chime Biologics serves a global clientele, offering a comprehensive suite of services from early-stage cell line development to commercial-scale manufacturing.

The company operates in the biopharmaceutical market, a sector that focuses on creating drugs from biological sources. Chime Biologics' business model is centered around providing end-to-end solutions, meaning they assist clients throughout the entire drug development and manufacturing process. This model allows the company to generate revenue by charging for their specialized services.

Chime Biologics' operations are powered by a team of over 400 skilled employees and advanced technology from its Shanghai Innovation Center. The company has a proven track record in Investigational New Drug (IND) enabling through Biologics License Application (BLA) filing at its Wuhan campus. IND and BLA are stages in the drug approval process, indicating that Chime Biologics can support clients from early research stages to regulatory approval.

The company's success is driven by its commitment to reliable, compliant, flexible, and fast-paced services. It aims to make cutting-edge biologics affordable and accessible to patients worldwide, reflecting its commitment to global health. Chime Biologics also places a high value on business integrity, professional compliance, and the protection of clients' intellectual property rights.

Source: Dealroom company data

At a glance

Status
Operational
Employees
30
Open positions
None listed
Dealroom signal
52.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Dec 2025 — — Wuhan Optics Valley Financial Holding Group ↗
SERIES AOther financing Feb 2023 $17M $625M Panacea Venture ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Chime Biologics website traffic

Latest recorded traffic for Chime Biologics is 2.9K monthly website visits, up 253.7% over the last three months. Chime Biologics's team grew 3.4% over the past year.

Latest monthly visits2.9K 3-month web change+253.7% 1-year team growth+3.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Chime Biologics in the Wuhan ecosystem

Live from Dealroom

The Chime Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇨🇳 China66.7%
🇺🇸 United States9.5%
🇨🇭 Switzerland9.5%
🇫🇷 France4.8%
🇯🇵 Japan4.8%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chime Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chime Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.